Severe Inflammatory Response in Myelodysplastic Syndrome and Trisomy 8 Following 23-Valent Polysaccharide Pneumococcal Vaccine Administration

• Hirohisa Fujikawa,
• Yusuke Miyazato,
• Kenichiro Ebisuda,
• Minoru Saito

Affiliations

Hirohisa Fujikawa

The University of Tokyo, International Research Center for Medical Education, Graduate School of Medicine, Department of Medical Education Studies, Tokyo, Japan

Yusuke Miyazato

National Center for Global Health and Medicine, Disease Control and Prevention Center, Tokyo, Japan

Kenichiro Ebisuda

Suwa Central Hospital, Department of Internal Medicine, Tamagawa, Japan

Minoru Saito

Suwa Central Hospital, Department of Internal Medicine, Tamagawa, Japan